• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Portfolio management

Vendis-backed Inula bolts on Veriditas Botanicals

  • José Rojo
  • José Rojo
  • 20 January 2016
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Inula, a Belgian aromatherapy group created by local GP Vendis Capital in January 2014, has entered the US market by purchasing Veriditas Botanicals.

An unquote" source explained that while Vendis helped Inula source and execute the acquisition, it did not support the deal financially.

Inula will use the Veriditas bolt-on as a stepping stone to the US market; the acquirer is expected to benefit from Veriditas's distributor and customer network across the Atlantic.

Veriditas Botanicals

  • DEAL:

    Portfolio management

  • LOCATION:

    Minneapolis

  • SECTOR:

    Personal products

  • FOUNDED:

    1995

The acquisition comes almost five years after Vendis became a shareholder in Pranarôm. In February 2011, the retail- and consumer-focused GP struck a deal with the company's CEO Dominique Baudoux to back its plan to grow in Belgium and abroad.

The deal, the third by Vendis since inception in 2009, was followed by the purchase of Belgian peer HerbalGem in January 2014. The add-on saw both aromatherapy laboratories merge into new player Inula; Vendis and Pranarôm's founder each secured a 45% holding, while the remaining 10% was picked up by HerbalGem's founder.

The resulting group came to operate local facilities in Ghislenghien and Vielsalm; subsidiaries in France, Spain and Italy; harvesting land in Belgium and Madagascar; and a worldwide network of distributors. 

The bolt-on is the second deal to involve Vendis in the space of a week and comes after the GP kickstarted the investment period for its second fund. On 13 January, the firm bought a majority stake in Dutch fashion brand Petrol Industries, with plans by Vendis to back an existing buy-and-build strategy, partner Vincent Braams told unquote".

Company
Created via the merger of Pranarôm and HerbalGem in 2014, Inula specialises in scientific aromatherapy products such as essential oils. With headquarters in Ghislenghien and Vielsalm, the group's products are sold by pharmacists and organic shops across more than 30 countries. Headquartered in Minneapolis, Veriditas Botanicals was founded in 1995 and sources its natural therapy products from smaller, family-owned organic farms across the US.

People
Vendis Capital – Cedric Olbrechts (co-founder, partner); Matthieu de Medeiros (investment director).
Inula – Sergio Calandri (CEO).
Veriditas Botanicals – Melissa Farris (founder).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Portfolio management
  • Consumer
  • Benelux
  • Belgium
  • Vendis Capital
  • Build-up

More on Portfolio management

An office building with a cloudy sky in the background
PlusServer owner BC Partners seeks sale via Jefferies as loan maturity looms

GP acquired the German cloud solutions group in 2017 via BC European Capital X

  • Exits
  • 15 August 2023
Runners passing the baton
Volpi raises EUR 250m continuation vehicle for 2016-vintage assets

Volpi Capital Investments Conti will hold Dutch geospatial data company Cyclomedia and UK-based surveillance group Digital Barriers

  • Secondaries
  • 28 June 2023
Bolt-ons and buy-and-build platforms
The Bolt-Ons Digest – 17 April 2023

Unquote’s selection of the latest add-ons with Triton's BFC Group, Seven2's Groupe Crystal, Palatine's FourNet and more

  • Expansion
  • 17 April 2023
Boardroom discussions and office openings
MJ Hudson business divisions acquired by Apex Group

Sale follows suspension of listed UK-headquartered asset management service provider’s shares in December 2022

  • Advisory
  • 11 April 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013